1 year return (CAGR)
45.34%
Halozyme Therapeutics Inc Exchange (NASDAQ, USD)
HALO
111.45
-1.00 (-0.89%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
40.11%
5 year return (CAGR)
22.15%
10 year return (CAGR)
27.19%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
12.65B
Price/Sales
7.60
Ent value
14.92B
Price/Book
88.12
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
30.58
PEG
-
Forward P/E
10.72
EPS growth
22.89%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 113.47 |
| Daily high | 113.47 |
| Daily low | 111.05 |
| Daily Volume | 2.86M |
| All-time high | 112.45 |
| 1y analyst estimate | 99.56 |
| Beta | 0.85 |
| EPS (TTM) | 3.41 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 24 Feb 2026 |
Downside potential
Loading...
Downside potential data
| HALO | S&P500 | |
| Current price drop from All-time high | -0.89% | -0.56% |
| Highest price drop | -74.26% | -56.47% |
| Date of highest drop | 4 Dec 2008 | 9 Mar 2009 |
| Avg drop from high | -31.54% | -10.68% |
| Avg time to new high | 35 days | 12 days |
| Max time to new high | 1209 days | 1805 days |
News
